Cargando…
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
BACKGROUND: With direct-acting antiviral agents (DAAs), mortality rates and causes of death among persons with hepatitis C virus (HCV) infection may change over time. However, the emergence of such trends may be delayed by the slow progression of chronic hepatitis C. To date, detailed analyses of ca...
Autores principales: | Roelens, Maroussia, Bertisch, Barbara, Moradpour, Darius, Cerny, Andreas, Semmo, Nasser, Schmid, Patrick, Müllhaupt, Beat, Clerc, Olivier, Semela, David, Junker, Christoph, Negro, Francesco, Keiser, Olivia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443104/ https://www.ncbi.nlm.nih.gov/pubmed/32855989 http://dx.doi.org/10.1093/ofid/ofaa308 |
Ejemplares similares
-
Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study
por: Brezzi, Matteo, et al.
Publicado: (2019) -
Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations
por: Bertisch, Barbara, et al.
Publicado: (2016) -
A prospective, multicenter, post-marketing observational study to measure the quality of life of HCV genotype 1 infected, treatment naïve patients suffering from fatigue and receiving 3D regimen: The HEMATITE study
por: Semmo, Nasser, et al.
Publicado: (2020) -
Assessing relative COVID-19 mortality: a Swiss population-based study
por: Hothorn, Torsten, et al.
Publicado: (2021) -
Mortality trends and causes of death among HIV positive patients at Newlands Clinic in Harare, Zimbabwe
por: Chimbetete, Cleophas, et al.
Publicado: (2020)